From T cell apoptosis to chronic immune activation in inflammatory diseases

International Archives of Allergy and Immunology

Volumn 164, Issue 2, 2014, Pages 140-146

  Citro, Alessandra ^a   Barnaba, Vincenzo ^a,b   Martini, Helene ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Pasteur Institute   (Italy)

Author keywords

Apoptosis; Cell death; Cross presentation

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALRETICULIN; CASPASE 3; CASPASE 7; CD40 LIGAND; EPITOPE; GAMMA INTERFERON; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; OLIGONUCLEOTIDE; PATTERN RECOGNITION RECEPTOR; PHOSPHATIDYLSERINE; POLYNUCLEOTIDE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ANTIGEN;

ANTIGEN PRESENTATION; APOPTOSIS; AUTOPHAGY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CHRONIC INFLAMMATION; CROSS PRESENTATION; CROSS TOLERANCE; CYTOKINE PRODUCTION; DENDRITIC CELL; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; MACROPHAGE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; EFFECTOR CELL; IMMUNE RESPONSE; INFLAMMATORY DISEASE; SELF CONCEPT;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; HUMANS; IMMUNE TOLERANCE; INFLAMMATION;

EID: 84907883501     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000363385     Document Type: Review

References (51)

1. Penaloza C, Lin L, Lockshin RA, Zakeri Z: Cell death in development: shaping the embryo. Histochem Cell Biol 2006; 126: 149-158.
2. Reed JC: Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol 2006; 3: 388-398.
3. Pellegrini M, Belz G, Bouillet P, Strasser A: Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc Natl Acad Sci USA 2003; 100: 14175-14180.
4. Barreiro R, Luker G, Herndon J, Ferguson TA: Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10. J Immunol 2004; 173: 1519-1525.
5. Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, Kroemer G: Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007; 14: 1237-1243.
6. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G; Nomenclature Committee on Cell Death 2009: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16: 3-11.
7. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
8. Griffith TS, Kazama H, Van Oosten RL, Earle JK Jr, Herndon JM, Green DR, Ferguson TA: Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J Immunol 2007; 178: 2679-2687.
9. Shi Y, Evans JE, Rock KL: Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425: 516-521.
10. Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, Kroemer G: Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 2009; 14: 364-375.
11. Ullrich E, Bonmort M, Mignot G, Kroemer G, Zitvogel L: Tumor stress, cell death and the ensuing immune response. Cell Death Differ 2008; 15: 21-28.
12. Rawson PM, Molette C, Videtta M, Altieri L, Franceschini D, Donato T, Finocchi L, Propato A, Paroli M, Meloni F, Mastroianni CM, d'Ettorre G, Sidney J, Sette A, Barnaba V: Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection. Nat Med 2007; 13: 1431-1439.
13. Chen W, Frank ME, Jin W, Wahl SM: TGFbeta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001; 14: 715-725.
14. Gao Y, Herndon JM, Zhang H, Griffith TS, Ferguson TA: Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med 1998; 188: 887-896.
15. Millar DG, Garza KM, Odermatt B, Elford AR, Ono N, Li Z, Ohashi PS: Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med 2003; 9: 1469-1476.
16. Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath S, Dhodapkar MV: Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 2007; 109: 4839-4845.
17. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA: Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32.
18. Matzinger P: The danger model: a renewed sense of self. Science 2002; 296: 301-305.
19. Bianchi ME: DAMP, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5.
20. Peter ME: ROS eliminate danger. Immunity 2008; 29: 1-2.
21. Propato A, Cutrona G, Francavilla V, Ulivi M, Schiaffella E, Landt O, Dunbar R, Cerundolo V, Ferrarini M, Barnaba V: Apoptotic cells overexpress vinculin and induce vinculinspecific cytotoxic T-cell cross-priming. Nat Med 2001; 7: 807-813.
22. Johansson U, Walther-Jallow L, Smed-Sorensen A, Spetz AL: Triggering of dendritic cell responses after exposure to activated, but not resting, apoptotic PBMCs. J Immunol 2007; 179: 1711-1720.
23. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, Nagata S: Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304: 1147-1150.
24. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
25. Battisto JR, Bloom BR: Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature 1966; 212: 156-157.
26. Ferguson TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, Green DR: Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness. J Immunol 2002; 168: 5589-5595.
27. Greene MI, Benacerraf B: Studies on hapten specific T cell immunity and suppression. Immunol Rev 1980; 50: 163-186.
28. Griffith TS, Ferguson TA: Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity 2011; 35: 456-466.
29. Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, Carbone FR: Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 2003; 301: 1925-1928.
30. Bevan MJ: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976; 143: 1283-1288.
31. Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998; 392: 86-89.
32. Carbone FR, Kurts C, Bennett SR, Miller JF, Heath WR: Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today 1998; 19: 368-373.
33. Schoenberger SP, van der Voort EI, Krietemeijer GM, Offringa R, Melief CJ, Toes RE: Cross-priming of CTL responses in vivo does not require antigenic peptides in the endoplasmic reticulum of immunizing cells. J Immunol 1998; 161: 3808-3812.
34. Ridge JP, Di Rosa F, Matzinger P: A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998; 393: 474-478.
35. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998; 393: 478-480.
36. Herndon JM, Stuart PM, Ferguson TA: Peripheral deletion of antigen-specific T cells leads to long-term tolerance mediated by CD8+ cytotoxic cells. J Immunol 2005; 174: 4098-4104.
37. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998; 101: 890-898.
38. Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, Griffith TS, Green DR, Schoenberger SP: CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005; 434: 88-93.
39. Gurung P, Kucaba TA, Schoenberger SP, Ferguson TA, Griffith TS: TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion. J Leukoc Biol 2010; 88: 1217-1225.
40. Gurung P, Kucaba TA, Ferguson TA, Griffith TS: Activation-induced CD154 expression abrogates tolerance induced by apoptotic cells. J Immunol 2009; 183: 6114-6123.
41. Barnaba V: Tuning cross-presentation of apoptotic T cells in immunopathology. Adv Exp Med Biol 2013; 785: 27-35.
42. Cron RQ: CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res 2003; 27: 185-202.
43. Castiglioni P, Martin-Fontecha A, Milan G, Tomajer V, Magni F, Michaelsson J, Rugarli C, Rosato A, Bellone M: Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cells. Cancer Res 2002; 62: 1116-1122.
44. Pang B, Neijssen J, Qiao X, Janssen L, Janssen H, Lippuner C, Neefjes J: Direct antigen presentation and gap junction mediated crosspresentation during apoptosis. J Immunol 2009; 183: 1083-1090.
45. López D, Garcia-Calvo M, Smith GL, Del Val M: Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes. J Immunol 2010; 184: 5193-5199.
46. + T cell responses to apoptotic selfantigens correlate with the chronic evolution of hepatitis C virus infection. PLoS Pathog 2012; 8:e1002759.
47. Lolli F, Martini H, Citro A, Franceschini D, Portaccio E, Amato MP, Mechelli R, Annibali V, Sidney J, Sette A, Salvetti M, Barnaba V: Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. J Neuroinflammation 2013; 10: 94.
48. Zehn D, Lee SY, Bevan MJ: Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009; 458: 211-214.
49. van Heijst JW, Gerlach C, Swart E, Sie D, Nunes-Alves C, Kerkhoven RM, Arens R, Correia-Neves M, Schepers K, Schumacher TN: Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient. Science 2009; 325: 1265-1269.
50. Nuti S, Rosa D, Valiante NM, Saletti G, Caratozzolo M, Dellabona P, Barnaba V, Abrignani S: Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998; 28: 3448-3455.
51. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA, Yuan J: Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005; 1: 112-119.